NCT05906186

Study Intestinal Complaints During Chemotherapy.

Name: Clinical Trial NCT05906186
Creator: Spaarne Gasthuis
Keywords: Constipation, kiwifruit, behavioral, clinical trial

Spaarne Gasthuis·ClinicalTrials.gov·behavioralNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Constipation
Drug/Device/Intervention: kiwifruit
Study type: Observational
Intervention type: behavioral

Sponsor & location

Primary sponsor: Spaarne Gasthuis

Timeline & enrollment

Phase: N/A
Start date: Sep 01, 2023
End date: May 30, 2024
Enrollment: 80 participants

Primary outcome

1. How common are constipation symptoms in patients undergoing chemotherapy treatment?

Summary

Study intestinal complaints during chemotherapy. A prospective study into intestinal complaints in patients undergoing chemotherapy treatment. A pre and post implementation design is used to establish if eating two kiwi fruits per day can prevent constipation.

ICD-10 classifications

ConstipationIrritable bowel syndrome with predominant constipation [IBS-C]Other laxativesPoisoning: Other laxativesOther functional intestinal disorders

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05906186
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05906186 through Pure Global AI's free database. This phase not specified trial is sponsored by Spaarne Gasthuis and is currently Not yet recruiting. The study focuses on Constipation. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.